Status:
RECRUITING
Left Bundle Branch Area Pacing in Heart Failure Patients With Ejection Fraction Below Normal
Lead Sponsor:
Seoul National University Hospital
Conditions:
Left Ventricular Ejection Fraction Less Then or Equal to 50percent
Eligibility:
All Genders
19+ years
Brief Summary
While cardiac resynchronization therapy remains the mainstay for advanced HF, it is not always feasible due to unfavorable anatomy of coronary sinus or pacing characteristics. In such cases, left bund...
Eligibility Criteria
Inclusion
- Patients previously diagnosed with heart failure with mid-range(or mildly reduced) ejection fraction and heart failure with reduced ejection fraction, which was documented by an appropriate echocardiographic study (Left ventricle ejection fraction \<50%), and
- Patients with indications of cardiac pacing or cardiac resynchronization therapy
Exclusion
- Patients aged less than 19 years.
- Pregnant.
- Patients with an expected life expectancy of less than 1 year.
- Patients with a mechanical valve for the tricuspid valve.
- Patients who need atrial pacing only.
- Patients who are not capable of receiving a transvenous pacemaker for any reason.
Key Trial Info
Start Date :
October 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06148571
Start Date
October 10 2023
End Date
December 31 2026
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, Jongno-gu, South Korea, 03080